Home › AVALON › Filing
🔔 Get instant alerts when AVALON files quarterly results on BSE Start free trial →

Press Release

Filed: 12 Nov 2026, 22:56 IST Exchange: NSE Category: Financial Results — Press Release
Press Release - Q2FY27 - Revenue 525.4 Cr +37.4% y-y; EBITDA 66.0 Cr +71.0% y-y; PAT 39.8 Cr +59.5% y-y - Revenue grew 8.5% q-o-q; gross margin at 34.1% - H1 FY27 revenue 1009.8 Cr +43.1% y-y; EBITDA margin improved 257 bps y-y - Signed MOU for 25 acres land with Tamil Nadu govt for advanced electronics manufacturing - Strategic JV formed with Zollner Elektronik AG for advanced EMS in India - India manufacturing delivered 17.1% EBITDA & 11.4% PAT in Q2 FY27 - Board approved preferential issue of warrants worth 425 Cr to Zollner (subject to EGM approval) - Net Working Capital days improved from 131 to 120 over last year
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 AVALON — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add AVALON to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Avalon Technologies Limited

Important. The summary above is generated automatically from Avalon Technologies Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.